Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2008-10-23

FDA Approved: ONDANSETRON — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for ondansetron filed by Glenmark Pharmaceuticals to update the label. Ondansetron is used to prevent nausea and vomitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (Zofran) (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)